In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


InforMax Inc.

Division of Thermo Fisher Scientific Inc.

Latest From InforMax Inc.

Step-Ups: Three Types of Deals Emerge for Public Biotechs

It's clearly a buyer's market in the public biotech sector. On the shopping list: products, chemistry, and cash.
BioPharmaceutical Business Strategies

Genomica Gives Up the Ghost

Less than two months after Genomica announced a change in strategic direction, resulting from disappointing market penetration of its third-party enterprise bioinformatics software, the company agreed to be acquired by Exelixis for $110 million in stock--precisely the amount of cash it was sitting on, making the deal in essence a back-door follow-on offering for Exelixis. The acquirer is therefore getting Genomica's software and technology base for a song, a fact that speaks volumes about the sustainability of a software-based bioinformatics business.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Thermo Fisher Scientific Inc.
  • Senior Management
  • Janet Lynch Lambert, Dir., Marketing
    David Charlton, Dir., IT/R&D
    John Marshall Green, Gen. Mgr.
    John Lippert, Dir., Sales
  • Contact Info
  • InforMax Inc.
    Phone: (240) 379-4000
    7305 Executive Way
    Frederick, MD 21704